BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 34953636)

  • 1. Treatment access for opioid use disorder in pregnancy among rural and American Indian communities.
    Kelley AT; Smid MC; Baylis JD; Charron E; Begaye LJ; Binns-Calvey A; Archer S; Weiner S; Pettey W; Cochran G
    J Subst Abuse Treat; 2022 May; 136():108685. PubMed ID: 34953636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of an unannounced standardized patient protocol to evaluate opioid use disorder treatment in pregnancy for American Indian and rural communities.
    Kelley AT; Smid MC; Baylis JD; Charron E; Binns-Calvey AE; Archer S; Weiner SJ; Begaye LJ; Cochran G
    Addict Sci Clin Pract; 2021 Jun; 16(1):40. PubMed ID: 34172081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Barriers to accessing opioid agonist therapy in pregnancy.
    Bedrick BS; O'Donnell C; Marx CM; Friedman H; Carter EB; Stout MJ; Kelly JC
    Am J Obstet Gynecol MFM; 2020 Nov; 2(4):100225. PubMed ID: 33345932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient and Community Factors Affecting Treatment Access for Opioid Use Disorder.
    Bulgin D; Patrick SW; McElroy T; McNeer E; Dupont WD; Murry VM
    Obstet Gynecol; 2023 Aug; 142(2):339-349. PubMed ID: 37473410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trending the evidence on opioid use disorder (OUD) continuum of care among rural American Indian/Alaskan Native (AI/AN) tribes: A systematic scoping review.
    Mpofu E; Ingman S; Matthews-Juarez P; Rivera-Torres S; Juarez PD
    Addict Behav; 2021 Mar; 114():106743. PubMed ID: 33359980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Pregnancy and Insurance Status With Treatment Access for Opioid Use Disorder.
    Patrick SW; Richards MR; Dupont WD; McNeer E; Buntin MB; Martin PR; Davis MM; Davis CS; Hartmann KE; Leech AA; Lovell KS; Stein BD; Cooper WO
    JAMA Netw Open; 2020 Aug; 3(8):e2013456. PubMed ID: 32797175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improving access to care via psychiatric clinical pharmacist practitioner collaborative management of buprenorphine for opioid use disorder.
    Pals H; Bratberg J
    J Am Pharm Assoc (2003); 2022; 62(4):1422-1429. PubMed ID: 35365405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Role of Primary Care in Improving Access to Medication-Assisted Treatment for Rural Medicaid Enrollees with Opioid Use Disorder.
    Cole ES; DiDomenico E; Cochran G; Gordon AJ; Gellad WF; Pringle J; Warwick J; Chang CH; Kim JY; Kmiec J; Kelley D; Donohue JM
    J Gen Intern Med; 2019 Jun; 34(6):936-943. PubMed ID: 30887440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Barriers and facilitators to nurse practitioner buprenorphine prescribing for opioid use disorder in primary care settings.
    Speight C; Caiola C; Tyndall DE; Scott ES
    J Am Assoc Nurse Pract; 2023 Feb; 35(2):112-121. PubMed ID: 36512806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment access for opioid use disorder among women with medicaid in Florida.
    Elmore AL; Patrick SW; McNeer E; Fryer K; Reid CN; Sappenfield WM; Mehra S; Salemi JL; Marshall J
    Drug Alcohol Depend; 2023 May; 246():109854. PubMed ID: 37001322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increasing buprenorphine access for veterans with opioid use disorder in rural clinics using telemedicine.
    Brunet N; Moore DT; Lendvai Wischik D; Mattocks KM; Rosen MI
    Subst Abus; 2022; 43(1):39-46. PubMed ID: 32078492
    [No Abstract]   [Full Text] [Related]  

  • 12. Pregnant Patients Using Opioids: Treatment Access Barriers in the Age of COVID-19.
    Lensch AC; Hairston E; Carter G; Jones HE
    J Addict Med; 2022 Jan-Feb 01; 16(1):e44-e47. PubMed ID: 33606424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reproductive-Age Women's Experience of Accessing Treatment for Opioid Use Disorder: "We Don't Do That Here".
    Phillippi JC; Schulte R; Bonnet K; Schlundt DD; Cooper WO; Martin PR; Kozhimannil KB; Patrick SW
    Womens Health Issues; 2021; 31(5):455-461. PubMed ID: 34090780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Telehealth for opioid use disorder treatment in low-barrier clinic settings: an exploration of clinician and staff perspectives.
    Aronowitz SV; Engel-Rebitzer E; Dolan A; Oyekanmi K; Mandell D; Meisel Z; South E; Lowenstein M
    Harm Reduct J; 2021 Nov; 18(1):119. PubMed ID: 34823538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trends and Disparities in Perinatal Opioid Use Disorder Treatment in Medicaid, 2007-2012.
    Landis RK; Stein BD; Dick AW; Griffin BA; Saloner BK; Terplan M; Faherty LJ
    Med Care Res Rev; 2024 Apr; 81(2):145-155. PubMed ID: 38160405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. County-level Factors and Treatment Access Among Insured Women With Opioid Use Disorder.
    Leech AA; McNeer E; Stein BD; Richards MR; McElroy T; Dupont WD; Patrick SW
    Med Care; 2023 Dec; 61(12):816-821. PubMed ID: 37199507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nurse Care Management for Opioid Use Disorder Treatment: The PROUD Cluster Randomized Clinical Trial.
    Wartko PD; Bobb JF; Boudreau DM; Matthews AG; McCormack J; Lee AK; Qiu H; Yu O; Hyun N; Idu AE; Campbell CI; Saxon AJ; Liu DS; Altschuler A; Samet JH; Labelle CT; Zare-Mehrjerdi M; Stotts AL; Braciszewski JM; Murphy MT; Dryden D; Arnsten JH; Cunningham CO; Horigian VE; Szapocznik J; Glass JE; Caldeiro RM; Phillips RC; Shea M; Bart G; Schwartz RP; McNeely J; Liebschutz JM; Tsui JI; Merrill JO; Lapham GT; Addis M; Bradley KA; ; Ghiroli MM; Hamilton LK; Hu Y; LaHue JS; Loree AM; Murphy SM; Northrup TF; Shmueli-Blumberg D; Silva AJ; Weinstein ZM; Wong MT; Burganowski RP
    JAMA Intern Med; 2023 Dec; 183(12):1343-1354. PubMed ID: 37902748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and treatment of opioid use disorders among primary care patients in six health systems.
    Lapham G; Boudreau DM; Johnson EA; Bobb JF; Matthews AG; McCormack J; Liu D; Samet JH; Saxon AJ; Campbell CI; Glass JE; Rossom RC; Murphy MT; Binswanger IA; Yarborough BJH; Bradley KA;
    Drug Alcohol Depend; 2020 Feb; 207():107732. PubMed ID: 31835068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. County-level access to opioid use disorder medications in medicare Part D (2010-2015).
    Abraham AJ; Adams GB; Bradford AC; Bradford WD
    Health Serv Res; 2019 Apr; 54(2):390-398. PubMed ID: 30665272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Pregnancy Recovery Center: A women-centered treatment program for pregnant and postpartum women with opioid use disorder.
    Krans EE; Bobby S; England M; Gedekoh RH; Chang JC; Maguire B; Genday P; English DH
    Addict Behav; 2018 Nov; 86():124-129. PubMed ID: 29884421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.